جست‌وجوی استاد و پژوهشگر

Lena Tingمشاهده پروفایل

استاد

• Neuromechanics
• Rehabilitation Engineering
• Motor Control
• +۶ مورد دیگر

Lena Ting is Professor and McCamish Foundation Distinguished Chair in Biomedical Engineering at Georgia Institute of Technology's College of Engineering, Coulter Department of Biomedical Engineering, with a secondary appointment in Rehabilitation Medicine at Emory University. She co-directs the Georgia Tech and Emory Neural Engineering Center and leads the Neuromechanics Lab. Her research spans Neuromechanics of movement control Rehabilitation engineering for Parkinson's disease and stroke Computational modeling of sensorimotor systems Human-robot interaction for gait rehabilitation Cortical correlates of balance control She bridges engineering, neuroscience, and physiology to address movement impairments in aging, cerebral palsy, and neurological disorders. Her 15 most recent publications (2024-2025) reveal strong focus on Cortical biomarkers for balance dysfunction Individual-specific gait signatures Neuromechanical modeling of spasticity Non-mechanical human-robot interaction Computational frameworks for sensorimotor control with significant applications in Parkinson's disease, stroke rehabilitation, and cerebral palsy. Scientific recognition includes: McCamish Foundation Distinguished Chair Blue Sky Award for Parkinson's research She directs the Neuromechanics Lab which develops robotic devices, computational models, and AI-driven approaches to personalize rehabilitation. Current projects include physiologically-inspired exoskeleton controllers, gait rehabilitation predictors for stroke survivors, and precise clinical assessment methods. She leads multiple grants including a $15M NSF grant on muscle dynamics and Parkinson's disease research.

• Calcium Signaling
• Smooth Muscle Physiology
• Cardiovascular Disease
• +۳ مورد دیگر

Karen Hannigan, Ph.D., serves as a Research Assistant Professor in the Department of Pharmacology at the University of Nevada, Reno School of Medicine, where her research centers on calcium signaling mechanisms in smooth muscle and cardiac cells and their implications for cardiovascular and gastrointestinal diseases. Her academic credentials include: B.S. in Anatomy from Queen's University Belfast, Northern Ireland Ph.D. in Physiology from Dundalk Institute of Technology, Ireland Dr. Hannigan's research program investigates dysregulation of Ca 2+ signaling in smooth muscle pathophysiology, with particular emphasis on gastrointestinal sphincters (internal anal sphincter and lower esophageal sphincter) and urogenital tissues (corpus cavernosum). Her work integrates cellular electrophysiology, calcium imaging, and pharmacological approaches to study ion channels—including BK Ca and Ano1—and their roles in muscle tone generation, pacemaker activity, and neuromuscular transmission across multiple species (mouse, monkey, rabbit). Analysis of her 15 most recent publications (2010–2020) reveals a cohesive research trajectory focused on smooth muscle physiology, with 60% of articles published between 2016–2020. Key thematic clusters include: (1) interstitial cells of Cajal as pacemakers in gastrointestinal motility, (2) β-adrenergic regulation of calcium channel dynamics in cardiac tissue, and (3) pharmacological modulation of BK Ca channels in erectile physiology. Her methodological rigor spans super-resolution imaging, comparative animal models, and translational investigations of motility disorders. No major scientific awards were documented in the source materials. Information regarding student mentorship, grant funding, or laboratory leadership was not provided in the available documentation. Research infrastructure details including laboratory facilities, collaborative teams, or ongoing projects were not specified in the source texts.

Lena H. Tingمشاهده پروفایل

استاد

• Neuromechanics
• Biomechanics
• Rehabilitation Engineering
• +۳ مورد دیگر

Lena H. Ting is a Professor of Biomedical Engineering at Georgia Institute of Technology, holding an adjunct position in the Woodruff School. Her research focuses on neuromechanics of movement, combining experimental, computational, and robotic approaches to study locomotion and balance in humans and animals. She leads efforts in rehabilitation technologies and robotics, with implications for prosthetics and physical therapy. Her work bridges biomechanics and neuroscience, addressing how neural systems interact with musculoskeletal dynamics. Education includes a B.S. in Mechanical Engineering from UC Berkeley (1990), M.S.E. in Biomechanical Engineering from Stanford (1993), and a Ph.D. in Mechanical Engineering from Stanford (1998). She completed postdoctoral fellowships in neurophysiology, including one in Paris. Research interests explore neuromechanical principles of movement control, including: Neuromechanical modeling of muscle coordination Neural control of posture and gait Robotics inspired by biological systems Rehabilitation engineering for spinal cord injury and cerebral palsy Her work integrates robotics, biomechanics, and clinical applications to develop innovative treatments and prosthetic devices. Awarded the American Physiological Society Arthur C. Guyton Award (2007), UC Berkeley Miller Visiting Professorship (2007), and multiple teaching honors including the Georgia Tech CETL/BP Junior Faculty Teaching Award (2006). Her contributions to biomechanics and education are widely recognized. Graduate students from her lab pursue careers in academia, industry (surgical robotics, biomechanics), and consulting. Notable alumni work in rehabilitation robotics and prosthetics development. Her lab collaborates across disciplines to advance neuromechanics research, including projects developing compliant robots for balance studies and analyzing motor control in impaired populations.

Reinier Boonمشاهده پروفایل

استاد

• Aging
• Non-coding RNA
• Cardiovascular Biology
• +۴ مورد دیگر

Reinier Boon serves as DZHK Professor for RNA Therapeutics at Goethe University Frankfurt, holding dual affiliations at the Institute for Cardiovascular Regeneration (Frankfurt, Germany) and the Department of Physiology at VU University Medical Center (Amsterdam, Netherlands). His research program, funded by the German Center for Cardiovascular Research (DZHK) and an ERC Starting Grant, focuses on molecular mechanisms of cardiovascular aging. Prof. Boon's laboratory investigates how non-coding RNAs regulate age-related deterioration in endothelial cells and cardiomyocytes, with particular emphasis on long non-coding RNAs (H19, Meg3, MALAT1) and microRNAs (miR-34a, miR-29). His work has identified critical roles for these molecules in cellular senescence, metabolic regulation, and vascular dysfunction, revealing novel pathways involving Stat3 signaling, KLF2 transcription factors, and extracellular matrix remodeling. This research bridges fundamental molecular biology with therapeutic development for age-related cardiovascular diseases. Analysis of his key publications (2011-2019) reveals a consistent trajectory from mechanistic discoveries in RNA biology to translational applications, with increasing focus on therapeutic targeting of non-coding RNAs in vascular aging and regenerative processes. The work spans endothelial metabolism, cardiac aging, neovascularization, and aortic pathology, demonstrating strong interdisciplinary integration of molecular cardiology, regenerative medicine, and RNA therapeutics. Major recognitions include: European Society of Cardiology Outstanding Achievement Award (2019) ERC Starting Grant (2015) Franz-Maximilian Groedel Research Prize (2014) Dutch-German Young Investigator Award (2013) American Heart Association Melvin L. Marcus Award (2010) Prof. Boon leads an internationally collaborative research group supported by DZHK infrastructure and competitive grants. His laboratory directs multiple projects on RNA-based interventions for cardiovascular aging, with strong emphasis on translational validation. The group maintains active collaborations across European cardiovascular research networks and participates in DZHK's therapeutic development initiatives. The Boon Group operates across two specialized sites: the Institute for Cardiovascular Regeneration at Frankfurt's Center for Molecular Medicine and Amsterdam's VU University Medical Center physiology department. As part of the DZHK's RNA Therapeutics program, the team combines advanced molecular techniques with disease models to develop novel strategies against age-related cardiovascular decline.

Michael Autieriمشاهده پروفایل

استاد

• Vascular Inflammation
• Anti-inflammatory Cytokines
• Vascular Occlusive Diseases
• +۵ مورد دیگر

Michael Autieri is a Professor and Director at the Lemole Center for Integrated Lymphatics and Vascular Research , Associate Director of the Cardiovascular Research Center , and holds affiliations with the Center for Metabolic Disease Research and Sol Sherry Thrombosis Research Center at Lewis Katz School of Medicine, Temple University . He earned his PhD from Hahnemann University in Philadelphia, PA. Research Focus: Regulation of vascular inflammation via endogenous anti-inflammatory cytokines (e.g., IL-19), mechanisms of atherosclerosis, restenosis, allograft vasculopathy, and therapeutic angiogenesis for peripheral vascular disease. Key Contributions: IL-19's role in macrophage polarization, cholesterol homeostasis, endothelial/smooth muscle proliferation, and mRNA stability. Recent work includes FXR1 regulation of vascular contractility, mitochondrial fission in hypertension, and neuro-lymphatic communication via CXCL12/CXCR4. Article Trends: Over 15 most recent publications, Autieri's work spans RNA biology (e.g., FXR1, ILF3), lymphatic-vascular crosstalk (e.g., IL-19, Prox1), metabolic-inflammatory syndromes (e.g., LDLRAP1, adipose dysfunction), and novel therapeutic targets (e.g., stress granules, chemokine signaling). His research integrates vascular biology , immunometabolism , and RNA regulatory networks to combat cardiovascular diseases.

Victor Rizzoمشاهده پروفایل

استاد

• Cardiovascular Disease
• Vascular Biology
• Molecular Signaling
• +۵ مورد دیگر

Victor Rizzo, PhD, FAHA, is a Professor in the Department of Cardiovascular Sciences at the Lewis Katz School of Medicine, Temple University. His research focuses on molecular signaling mechanisms in vascular dysfunction, particularly exploring caveolae, mitochondria, and extracellular vesicles in diseases like atherosclerosis and aneurysm formation. His lab utilizes advanced microscopy, biochemistry, and in vivo/in vitro models to study organelle signaling in endothelial and smooth muscle cells. Education: PhD in Cell Biology (Angiogenesis) from New Jersey Medical School, followed by postdoctoral training in Mechanotransduction at the University of Pennsylvania and Caveolae studies at Harvard Medical School. BS in Biology from Farleigh Dickinson University. Key research areas include: caveolae as flow-sensing organelles, mitochondrial signaling in vascular health/disease, and extracellular vesicle-mediated communication. Recent work emphasizes mitochondrial fission's role in hypertension and aneurysm development, as well as therapeutic targeting strategies. Selected achievements include FAHA fellowship recognition. Major publications span over 30 years, focusing on angiotensin II signaling pathways, vascular remodeling mechanisms, and organelle biology. Collaborative projects explore exosome roles in intercellular signaling and novel therapeutic approaches targeting mitochondrial dynamics.

George F. Richمشاهده پروفایل

استاد

• Cardiovascular Engineering
• Anesthesiology
• Biomedical Engineering
• +۷ مورد دیگر

George F. Rich is the Harrison Medical Teaching Professor and Chair of the Department of Anesthesiology at the University of Virginia School of Medicine. He also holds a professorship in the Department of Biomedical Engineering, reflecting his interdisciplinary expertise. His clinical and research leadership is central to the department's mission in education, patient care, and research. Dr. Rich earned his B.S. in Mechanical Engineering, M.D., and Ph.D. in Bioengineering, all from the University of Utah. This unique combination of training underpins his research at the intersection of engineering and medicine. His research focuses on cardiovascular engineering, particularly the role of endothelial pathways in vascular regulation. Key areas include the nitric oxide/guanylate cyclase system, inhaled nitric oxide therapy for pulmonary hypertension, and vascular dysfunction in sepsis. Using chronic hypoxia rat models and isolated organ systems, his lab investigates both acute and long-term vascular responses with direct clinical relevance. His recent publications reveal a consistent focus on nitric oxide signaling, pulmonary vasoconstriction, and inflammatory modulation in animal models. The work spans physiology, pharmacology, and critical care, demonstrating translational impact. Effects of anesthesia on endothelium and vascular smooth muscle Dr. Rich leads significant research initiatives funded by grants related to vascular function and anesthesia. While specific students are not listed, his role as a professor and research leader implies active mentorship of trainees and junior scientists. He also contributes to medical education as a named teaching professor. His laboratory work involves integrated physiological models including isolated lung and kidney preparations, complemented by molecular techniques such as western blotting, light microscopy, and radioimmunoassays, forming a comprehensive approach to studying vascular tone and endothelial health.

Anja Meissnerمشاهده پروفایل

استاد

• Vascular Physiology
• Cardiovascular Disease
• Neurovascular Biology
• +۶ مورد دیگر

Prof. Dr. Anja Meissner is a leading physiologist at the University of Augsburg's Medical School, specializing in vascular biology with affiliations to Lund University and DZNE Bonn. Her research focuses on Sphingosine-1-phosphate (S1P) signaling in cardiovascular diseases, hypertension, and neurovascular interactions. University of Augsburg, Medical School Lund University collaborations DZNE Bonn partnerships Research Highlights: Investigates immune system roles in hypertension, heart failure's target organ effects, S1P pathway in stroke, cardiovascular risk factors' impact on brain function, and environmental influences on vascular health. Key methods include non-invasive imaging , flow cytometry , and in vitro/ex vivo models . Publication Trends: Recent work emphasizes microfluidic neurovascular models , glymphatic system dysfunction , and sex-specific cardiovascular responses . Collaborations span neurology, cardiology, and environmental science institutions. Awards & Grants: DFG Project Funding (2025-2028) Hjärnfonden Grant (2024-2025) Albert Påhlsson Foundation (2022-2025) Swedish Research Council (2023-2026) Educational Impact: Mentored 15+ PhD students including Lotte Vanherle and Frank Matthes. Leads international research teams with scholars from Sweden, Belgium, Italy, and Canada. Current grants focus on CFTR therapeutics and sex-specific hypertension consequences .

Ryan A Harrisمشاهده پروفایل

دانشیار

• Vascular Physiology
• Exercise Physiology
• Cardiovascular Disease
• +۵ مورد دیگر

Ryan A Harris serves as Associate Professor at Augusta University's Medical College of Georgia with appointments across the Department of Medicine, Population Health Science, Pediatrics, and Physiology. He directs the Laboratory of Integrative Vascular and Exercise Physiology (LIVEP) and holds the title of Associate Director within the Georgia Prevention Institute. Education: Ph.D. in Exercise Physiology, Indiana University (2007) M.S. in Kinesiology and Exercise Science, California State University (2002) B.S. in Kinesiology and Exercise Science, San Diego State University (1999) Harris's research centers on vascular dysfunction mechanisms in clinical populations including cystic fibrosis, COPD, diabetes, and hypertension. His work investigates endothelial dysfunction through flow-mediated dilation measurements, oxidative stress pathways, and sex-specific responses to vascular stressors. Current projects explore estrogen's cardioprotective role, endothelin receptor function, and vascular impacts of cancer therapies. His most recent publications reveal emerging trends in cardio-oncology (particularly prostate/breast cancer vascular complications), racial disparities in microvascular function, and novel exercise interventions for cystic fibrosis. Key themes include endothelial dysfunction as a cross-cutting mechanism in chronic diseases, the role of oxidative stress in exercise intolerance, and precision approaches to vascular assessment. Scientific Awards: ACSM Fellowship (2012) NIH Loan Repayment Award (2010) Exemplary Teaching Awards (2015, 2017) Emerging Scientist Award (2014) Outstanding Young Faculty Award (2014) Harris leads multiple NIH-funded projects including R01 mechanisms studying vascular dysfunction in cystic fibrosis and COPD. He mentors graduate students within LIVEP while serving on university committees including the Faculty Senate Executive Committee and NIH PRIDE Mentorship program. His editorial roles span Journal of Applied Physiology and Medicine & Science in Sports & Exercise. The LIVEP laboratory (600 sq ft) houses advanced equipment including GE Logiq ultrasound systems, metabolic carts, and arterial stiffness measurement devices. Current research teams focus on cystic fibrosis vascular function, cancer-related cardiovascular complications, and hypertension mechanisms through the Stress Related Mechanisms of Hypertension Risk program (P01HL069999).

• Vascular Diseases
• Perivascular Adipose Tissue (PVAT)
• AMP-activated Protein Kinase (AMPK)
• +۵ مورد دیگر

Professor Simon Kennedy is a Professor of Vascular Pharmacology within the School of Cardiovascular & Metabolic Health at the University of Glasgow, where he has been a faculty member since 2006. He currently serves as the Senior Senate Assessor for Student Conduct and holds various administrative roles including membership on the University Court, Education Policy & Strategy Committee, Finance Committee, and Audit and Risk Committee. Additionally, he is actively involved with the British Pharmacological Society, serving on their Finance and Awards Committees, and is a member of the editorial boards of two top-ranking pharmacology journals. Professor Kennedy's primary research focuses on vascular diseases and comorbidities, with particular emphasis on the role of perivascular adipose tissue (PVAT) in vascular function. His work investigates the effects of AMP-activated protein kinase (AMPK) within PVAT and the vascular wall, the impact of hypoxia on sphingosine kinase (SK) expression and function, and the role of connexins in cell communication affecting vascular function in both pulmonary and systemic circulations. His research spans cellular signaling mechanisms and vascular structure and function. Analysis of his recent publications reveals a consistent focus on vascular pharmacology with particular emphasis on AMPK signaling pathways, perivascular adipose tissue function, and vascular responses to various stressors. His work demonstrates strong interdisciplinary collaboration across pharmacology, vascular biology, and biomedical engineering, with increasing focus on translational applications including drug-eluting stent technology and vascular monitoring systems. Professor Kennedy serves as the coordinator for Level 4 of the Pharmacology degree program and teaches various final-year options, including an in vivo skills course funded by a British Pharmacological Society teaching grant. He acts as an academic advisor to approximately 40 undergraduate students and contributes to teaching across multiple degree programs including MBChB and BDS degrees. His external academic engagements include serving as an external examiner at two Russell Group universities and as treasurer of the Scottish Cardiovascular Forum. His research is conducted through the Cellular Signalling & Mechanisms and Vascular Structure & Function research groups, where he collaborates with colleagues within the School of Cardiovascular & Metabolic Health, College of Science and Engineering, and external partners. His work bridges basic science with clinical applications, particularly in understanding vascular pathophysiology and developing therapeutic approaches for vascular diseases.

Annarita DiLorenzoمشاهده پروفایل

استاد

• Vascular Biology
• Endothelial Function
• Sphingolipid Metabolism
• +۷ مورد دیگر

Annarita DiLorenzo is a Professor in the Department of Pathology and Laboratory Medicine at Weill Cornell Medical College, where she also holds a position in the Graduate School of Medical Sciences. She leads a research laboratory focused on vascular and sphingolipid biology, with a strong emphasis on endothelial function, nitric oxide signaling, and lipid metabolism in cardiovascular disease. Her research interests center on the molecular mechanisms regulating vascular permeability, inflammation, and blood pressure. Key areas include the role of endothelial nitric oxide synthase (eNOS) and the ER protein Nogo-B in controlling endothelial barrier function and vascular tone. She investigates how sphingolipids such as ceramide and sphingosine-1-phosphate (S1P) influence vascular homeostasis, atherosclerosis, and cardiac hypertrophy. Her recent publications reveal a consistent focus on endothelial sphingolipid metabolism, particularly the balance between ceramide and S1P, and its impact on hypertension, coronary atherosclerosis, and cerebrovascular health. The work integrates molecular biology, lipid signaling, and vascular physiology, often using genetically modified mouse models to dissect pathway-specific effects. Dr. DiLorenzo's research is supported by grants from the National Institutes of Health (NIH), the American Heart Association (AHA), and the Harold S. Geneen Charitable Trust, reflecting the significance and translational potential of her work. She mentors postdoctoral researchers and collaborates extensively within the institution. Her laboratory team includes Olivia Garnier and Onorina Laura Manzo, both postdoctoral associates.

• Respiratory Physiology
• Airway Smooth Muscle
• Asthma
• +۳ مورد دیگر

Associate Professor Peter McFawn is a faculty member at the School of Human Sciences, University of Western Australia. He holds a BSc and PhD from UWA and completed a research fellowship at Queen's University, Canada. His primary research focuses on respiratory physiology, particularly airway smooth muscle mechanics and their role in conditions like asthma and COPD. He teaches courses in physiology at UWA's Perth and Singapore campuses, including advanced cellular physiology and physiological control mechanisms. Current research projects include studying computer-controlled muscle oscillations, cellular components of stress responses, and COPD-induced airway damage. Collaborators include Prof. Howard Mitchell and clinicians at Charles Gardener Hospital. His research contributes to UN Sustainable Development Goals related to health and well-being. Over 49 research outputs and 7 grants highlight his work in pulmonary physiology and muscle dysfunction. He has supervised one PhD project on COPD comparison studies and maintains active collaborations across multiple institutions.

Peter W Abelمشاهده پروفایل

استاد

• G Protein-Coupled Receptors
• Adrenergic Receptors
• Neuropeptide Receptors
• +۸ مورد دیگر

Peter W. Abel is a Professor and Chair of the Department of Pharmacology and Neuroscience at Creighton University School of Medicine. His research focuses on G protein-coupled receptors (GPCRs) and their signaling mechanisms in diseases like asthma, pulmonary hypertension, and cancers. University: Creighton University School: School of Medicine Department: Department of Pharmacology and Neuroscience Academic Rank: Professor Research Interests: Dr. Abel investigates adrenergic receptors, calcitonin gene-related peptide (CGRP) receptors, and regulatory mechanisms in smooth muscle and cancer cells. His work explores: GPCR signaling pathways in airway and vascular dysfunction Role of RGS2 in airway hyperresponsiveness and remodeling Epigenetic regulation of P-Rex1 and RGS2 in cancer metastasis Development of irreversible peptide antagonists for CGRP receptors Recent Publication Trends: His studies span asthma (RGS2 repression, P-Rex1 upregulation), prostate and breast cancer (epigenetic changes, PKCε pathways), and chemical synthesis of receptor ligands. Collaborative work includes cytokine networks in corticosteroid resistance. Lab Members: Current researchers include PhD candidate Cameron Kieffer, undergraduate Julia Chowdhury, and medical students David Maas and Nate Rosol. Collaborators: Dr. Charles Bockman (Assistant Professor) and Dr. David Smith (Associate Professor).

Annarita Di Lorenzoمشاهده پروفایل

استاد

• Vascular Biology
• Sphingolipid Metabolism
• Cardiovascular Research
• +۵ مورد دیگر

Annarita Di Lorenzo is a Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College. She has established herself as a leading researcher in vascular biology and sphingolipid metabolism, with a particular focus on endothelial function and cardiovascular diseases. Her work bridges basic science with clinical applications, aiming to understand the molecular mechanisms underlying vascular homeostasis and disease. Dr. Di Lorenzo received her M.Sc. in 2001 and Ph.D. in 2004 from the University of Naples "Federico II" in Italy. Her academic journey has led her to become a prominent figure in cardiovascular research at Weill Cornell Medicine. Dr. Di Lorenzo's research primarily focuses on sphingolipid signaling pathways in vascular biology. Her laboratory investigates how sphingolipids, particularly sphingosine-1-phosphate (S1P) and ceramide, regulate endothelial function, blood pressure, and vascular homeostasis. A significant portion of her work examines the role of Nogo proteins (particularly Nogo-B) in vascular function and disease. She has made important contributions to understanding how sphingolipid metabolism influences atherosclerosis, hypertension, and metabolic syndrome. Her research often combines molecular, cellular, and whole-animal approaches to elucidate mechanisms of vascular dysfunction and identify potential therapeutic targets. Analysis of Dr. Di Lorenzo's recent publications reveals a strong emphasis on sphingolipid metabolism in vascular function. Her work consistently explores the balance between S1P and ceramide in endothelial cells and how this balance affects vascular tone, blood pressure, and atherosclerosis. She has pioneered research on Nogo proteins in vascular biology, demonstrating their critical role in regulating sphingolipid biosynthesis. Her publications span high-impact journals in cardiovascular biology, including Circulation Research , Nature Communications , and Cell Metabolism , reflecting the significance of her contributions to the field. Principal Investigator: "Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaques" (2024-2025, National Institute of Neurological Disorders & Stroke) Principal Investigator: "Sphingolipid Biology of macrophage in Coronary Atherosclerosis Development and Progression" (2022-2027, National Heart, Lung, & Blood Institute) Dr. Di Lorenzo's laboratory represents a sophisticated integration of molecular biology, vascular physiology, and translational medicine, positioning her as a leader in the emerging field of vascular sphingolipid biology. Her work has important clinical implications for understanding and treating hypertension, atherosclerosis, and other cardiovascular conditions that affect millions worldwide.

Mildred A. Pointerمشاهده پروفایل

استاد

• Salt-sensitive Hypertension
• Stress-related Kidney Disease
• Calcium Signaling in Cardio-metabolic Disease
• +۱ مورد دیگر

Dr. Mildred A. Pointer is a Professor and Chairperson of the Department of Biology at Howard University. With continuous funding since 2005, she has secured over $5.3 million as Principal Investigator and $8 million as co-PI for research on hypertension and renal physiology. B.S. in Biology, NC Central University (1974) Ph.D. in Physiology, Wake Forest University (1983) Her research focuses on renal physiology , particularly: Mechanisms of salt-sensitive hypertension Stress-induced kidney and cardiovascular disease Role of calcium signaling in cardio-metabolic disorders Recent publications highlight her work on: Sex differences in stress-related kidney injury Calcium dynamics in hypertension models Psychosocial factors in blood pressure regulation Scientific awards include: AHA Career Development Award (2018) Founding member of the American Society of Hypertension NIH SCOR Grant contributions (1995-2000) AstraZeneca Pharmaceutical Award (1998-2001) Her research has been supported by: NIMHD U54 RCMI Grant (2017-2022) examining stress and kidney disease in African American males Dr. Pointer has led studies on: Racial health disparities in hypertension Renal denervation effects in animal models Thrombolytic therapy and vascular integrity